Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 Vaccines
William Borkowsky(New York University), Eleanor Jiménez(University of Miami), Elizabeth J. McFarland(University of Colorado Anschutz Medical Campus), Russell Van Dyke(Cancer Research And Biostatistics), Stephen A. Spector(University of California San Diego), Anne‐Marie Duliège(Sunesis (United States)), Lisa M. Frenkel(Infectious Disease Research Institute), Sandra Burchett(Harvard University), Donald Francis(SUNY Upstate Medical University), Stuart E. Starr, Terry Fenton(Harvard University), James McNamara(National Institute of Allergy and Infectious Diseases), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Minhee Kang(Cancer Research And Biostatistics), Diane W. Wara(University of California, San Francisco), Coleen K. Cunningham(Duke Medical Center), Yvonne J. Bryson(Oklahoma State University Center for Health Sciences)
Cited by 53
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896